Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 6, 2010, Pages 369-378

  Eftekhari, Sajedeh ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

brainstem; calcitonin gene related peptide; calcitonin gene related peptide antagonists; migraine; trigeminal ganglion

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; ANTIMIGRAINE AGENT; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; OLCEGEPANT; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; TELCAGEPANT; TRIPTAN DERIVATIVE;

ACUTE MIGRAINE; AMYGDALOID NUCLEUS; BRAIN STEM; CEREBELLUM; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORPUS STRIATUM; DRUG BINDING SITE; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; HUMAN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MIGRAINE; NERVOUS SYSTEM; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SPINAL CORD; TRIGEMINUS GANGLION;

EID: 78649940547     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285610388343     Document Type: Review

References (84)

1. Bahra, A., Matharu, M.S., Buchel, C., Frackowiak, R.S. and Goadsby, P.J. ( 2001) Brainstem activation specific to migraine headache. Lancet 357: 1016-1017.
2. Barth, S.W., Riediger, T., Lutz, T.A. and Rechkemmer, G. ( 2004) Peripheral amylin activates circumventricular organs expressing calcitonin receptor a / B subtypes and receptor-activity modifying proteins in the rat. Brain Res 997: 97-102.
3. Bellamy, J.L., Cady, R.K. and Durham, P.L. ( 2006) Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46: 24-33.
4. Brighina, F., Palermo, A., Panetta, M.L., Daniele, O., Aloisio, A., Cosentino, G. et al. (2009) Reduced cerebellar inhibition in migraine with aura: A TMS study. Cerebellum 8: 260-266.
5. Capuano, A., de Corato, A., Lisi, L., Tringali, G., Navarra, P. and Dello Russo, C. ( 2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: Relevance for migraine pathology. Mol Pain 5: 43.
6. Chan, K., Edvinsson, L., Eftekhari, S., Kimblad, P.O., Kane, S., Lynch, J. et al. (2010) Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther 334: 746-752.
7. Connor, K.M., Shapiro, R.E., Diener, H.C., Lucas, S., Kost, J., Fan, X. et al. (2009) Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 73: 970-977.
8. Cottrell, G.S., Roosterman, D., Marvizon, J.C., Song, B., Wick, E., Pikios, S. et al. (2005) Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 490: 239-255.
9. Diener, H.C. ( 1997) Positron emission tomography studies in headache. Headache 37: 622-625.
10. Doods, H., Arndt, K., Rudolf, K. and Just, S. ( 2007) CGRP antagonists: Unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28: 580-587.
11. Dublin, P. and Hanani, M. ( 2007) Satellite glial cells in sensory ganglia: Their possible contribution to inflammatory pain. Brain Behav Immun 21: 592-598.
12. Durham, P.L. ( 2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1): S3-S8. Edvinsson, L. (2008) CGRP-receptor antagonism in migraine treatment. Lancet 372: 2089-2090.
13. Edvinsson, L., Brodin, E., Jansen, I. and Uddman, R. ( 1988) Neurokinin a in cerebral vessels: Characterization, localization and effects in vitro. Regul Pept 20: 181-197.
14. Edvinsson, L., Cantera, L., Jansen-Olesen, I. and Uddman, R. ( 1997) Expression of calcitonin gene-related peptide 1 receptor mRNA in human trigeminal ganglia and cerebral arteries. Neurosci Lett 229: 209-211.
15. Edvinsson, L., Chan, K.Y., Eftekhari, S., Nilsson, E., de Vries, R., Säveland, H. et al. (2010) Effect of the calcitonin gene-related (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 30: 1233-1240.
16. Edvinsson, L., Ekman, R., Jansen, I., Mcculloch, J. and Uddman, R. ( 1987) Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. J Cereb Blood Flow Metab 7: 720-728.
17. Edvinsson, L., Fredholm, B.B., Hamel, E., Jansen, I. and Verrecchia, C. ( 1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58: 213-217.
18. Edvinsson, L. and Goadsby, P.J. ( 1990) Extracerebral manifestations in migraine. A peptidergic involvement? J Intern Med 228: 299-304.
19. Edvinsson, L., Gulbenkian, S., Barroso, C.P., Cunhae Sa, E., Sa, M., Polak, J.M., Mortensen, A. et al. (1998) Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 19: 1213-1225.
20. Edvinsson, L. and Ho, T.W. (2010 b) CGRP receptor antagonism and migraine. Neurotherapeutics 7: 164-175.
21. Edvinsson, L. and Linde, M. (2010) New drugs in migraine treatment and prophylaxis: Telcagepant and topiramate. Lancet 376: 645-655.
22. Edvinsson, L. and Tfelt-Hansen, P. ( 2008) The blood-brain barrier in migraine treatment. Cephalalgia 28: 1245-1258.
23. Eftekhari, S. and Edvinsson, L. ( 2010) Immunoreactivity of calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus. In European Headache and Migraine Trust International Congress, October, abstract.
24. Eftekhari, S., Edvinsson, L., Salvatore, C.A. and Warfvinge, K. ( 2010a) Cerebellar Distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat. In European Headache and Migraine Trust International Congress, October, abstract.
25. Eftekhari, S., Salvatore, C.A., Calamari, A., Kane, S.A., Tajti, J. and Edvinsson, L. (2010 b) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169: 683-696.
26. Evans, B.N., Rosenblatt, M.I., Mnayer, L.O., Oliver, K.R. and Dickerson, I.M. ( 2000) CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275: 31438-31443.
27. Foord, S.M. and Marshall, F.H. ( 1999) RAMPs: Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 20: 184-187.
28. Gibson, S.J., Polak, J.M., Bloom, S.R., Sabate, I.M., Mulderry, P.M., Ghatei, M.A. et al. (1984) Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci 4: 3101-3111.
29. Goadsby, P.J. ( 2005) Advances in the understanding of headache. Br Med Bull 73-74: 83-92.
30. Goadsby, P.J. ( 2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13: 39-44.
31. Goadsby, P.J. and Edvinsson, L. ( 1993) The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33: 48-56.
32. Goadsby, P.J., Edvinsson, L. and Ekman, R. ( 1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23: 193-196.
33. Goadsby, P.J., Edvinsson, L. and Ekman, R. ( 1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28: 183-187.
34. Gregg, K.V., Bishop, G.A. and King, J.S. ( 1999) Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. J Neurocytol 28: 431-438.
35. Gulbenkian, S., Saetrum Opgaard, O., Ekman, R., Costa Andrade, N., Wharton, J., Polak, J.M. et al. (1993) Peptidergic innervation of human epicardial coronary arteries. Circ Res 73: 579-588.
36. Gulbenkian, S., Uddman, R. and Edvinsson, L. ( 2001) Neuronal messengers in the human cerebral circulation. Peptides 22: 995-1007.
37. Gupta, S., Mehrotra, S., Villalon, C.M., Garrelds, I.M., de Vries, R., van Kats, J.P. et al. (2006) Characterisation of CGRP receptors in human and porcine isolated coronary arteries: Evidence for CGRP receptor heterogeneity. Eur J Pharmacol 530: 107-116.
38. Hagner, S., Haberberger, R., Kummer, W., Springer, J., Fischer, A., Bohm, S. et al. (2001) Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRP)-1 in the endothelium of human coronary artery and bronchial blood vessels. Neuropeptides 35: 58-64.
39. Hanani, M. ( 2005) Satellite glial cells in sensory ganglia: From form to function. Brain Res Brain Res Rev 48: 457-476.
40. Hay, D.L., Poyner, D.R. and Quirion, R. ( 2008) International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 60: 143-145.
41. Ho, T.W., Edvinsson, L. and Goadsby, P.J. (2010) CGRP receptor antagonism provides new insights into migraine pathophysiology. Nat Rev Neurol 6: 573-582.
42. Ho, T.W., Ferrari, M.D., Dodick, D.W., Galet, V., Kost, J., Fan, X. et al. (2008 a) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial. Lancet 372: 2115-2123.
43. Ho, T.W., Mannix, L.K., Fan, X., Assaid, C., Furtek, C., Jones, C.J. et al. (2008 b) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70: 1304-1312.
44. Hokfelt, T., Arvidsson, U., Ceccatelli, S., Cortes, R., Cullheim, S., Dagerlind, A. et al. (1992) Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems. Ann N Y Acad Sci 657: 119-134.
45. Hou, M., Kanje, M., Longmore, J., Tajti, J., Uddman, R. and Edvinsson, L. ( 2001) 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res 909: 112-120.
46. Inagaki, S., Kito, S., Kubota, Y., Girgis, S., Hillyard, C.J. and Macintyre, I. ( 1986) Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains. Brain Res 374: 287-298.
47. Just, S., Arndt, K. and Doods, H. ( 2005) The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes. Neurosci Lett 381: 120-124.
48. Kawai, Y., Takami, K., Shiosaka, S., Emson, P.C., Hillyard, C.J., Girgis, S. et al. (1985) Topographic localization of calcitonin gene-related peptide in the rat brain: An immunohistochemical analysis. Neuroscience 15: 747-763.
49. Kristiansen, K.A. and Edvinsson, L. ( 2010) Neurogenic inflammation, a study of rat trigeminal ganglion. J Headache Pain; DOI 10.1007/s10194-010-0260-x.
50. Lennerz, J.K., Ruhle, V., Ceppa, E.P., Neuhuber, W.L., Bunnett, N.W., Grady, E.F. et al. (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507: 1277-1299.
51. Li, J., Vause, C.V. and Durham, P.L. ( 2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196: 22-32.
52. Liu, Y., Broman, J., Zhang, M. and Edvinsson, L. (2009) Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats. Cephalalgia 29: 935-948.
53. Lynch, J., Regan, C., Edvinsson, L., Hargreaves, R. and Kane, S. (2010) Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries. J Cardiovasc Pharmacol 55: 518-521.
54. Lynch, J.J., Shen, Y.T., Pittman, T.J., Anderson, K.D., Koblan, K.S., Gould, R.J. et al. (2009) Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs. Eur J Pharmacol 623: 96-102.
55. May, A. and Goadsby, P.J. ( 1999) The trigeminovascular system in humans: Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19: 115-127.
56. Mclatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N. et al. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339.
57. Morara, S., Provini, L. and Rosina, A. ( 1989) CGRP expression in the rat olivocerebellar system during postnatal development. Brain Res 504: 315-319.
58. Morara, S., Rosina, A., Provini, L., Forloni, G., Caretti, A. and Wimalawansa, S.J. ( 2000) Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: An autoradiographic and immunohistochemical analysis. Neuroscience 100: 381-391.
59. Morara, S., van der Want, J.J., de Weerd, H., Provini, L. and Rosina, A. ( 2001) Ultrastructural analysis of climbing fiber-Purkinje cell synaptogenesis in the rat cerebellum. Neuroscience 108: 655-671.
60. Morara, S., Wang, L.P., Filippov, V., Dickerson, I.M., Grohovaz, F., Provini, L. et al. (2008) Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices. Eur J Neurosci 28: 2213-2220.
61. Morara, S., Wimalawansa, S.J. and Rosina, A. ( 1998) Monoclonal antibodies reveal expression of the CGRP receptor in Purkinje cells, interneurons and astrocytes of rat cerebellar cortex. Neuroreport 9: 3755-3759.
62. Moreno, M.J., Cohen, Z., Stanimirovic, D.B. and Hamel, E. ( 1999) Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture. J Cereb Blood Flow Metab 19: 1270-1278.
63. Moskowitz, M.A. ( 1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43: S16-S20.
64. Moskowitz, M.A., Reinhard Jr, J.F., Romero, J., Melamed, E. and Pettibone, D.J. ( 1979) Neurotransmitters and the fifth cranial nerve: Is there a relation to the headache phase of migraine? Lancet 2: 883-885.
65. Olesen, J., Diener, H.C., Husstedt, I.W., Goadsby, P.J., Hall, D., Meier, U. et al. (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350: 1104-1110.
66. Oliver, K.R., Kane, S.A., Salvatore, C.A., Mallee, J.J., Kinsey, A.M., Koblan, K.S. et al. (2001) Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci 14: 618-628.
67. Oliver, K.R., Wainwright, A., Edvinsson, L., Pickard, J.D. and Hill, R.G. ( 2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22: 620-629.
68. Pietrobon, D. ( 2007) Familial hemiplegic migraine. Neurotherapeutics 4: 274-284.
69. Poyner, D.R. ( 1992) Calcitonin gene-related peptide: Multiple actions, multiple receptors. Pharmacol Ther 56: 23-51.
70. Regan, C.P., Stump, G.L., Kane, S.A. and Lynch Jr, J.J. ( 2009) Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis. J Pharmacol Exp Ther 328: 571-578.
71. Sams, A. and Jansen-Olesen, I. ( 1998) Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries. Neurosci Lett 258: 41-44.
72. Sexton, P.M., Mckenzie, J.S. and Mendelsohn, F.A. ( 1988) Evidence for a new subclass of calcitonin / calcitonin gene-related peptide binding site in rat brain. Neurochem Int 12: 323-335.
73. Skofitsch, G. and Jacobowitz, D.M. ( 1985) Calcitonin gene-related peptide: Detailed immunohistochemical distribution in the central nervous system. Peptides 6: 721-745.
74. Smith, D., Hill, R.G., Edvinsson, L. and Longmore, J. ( 2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia 22: 424-431.
75. Strata, P., Thach, W.T. and Ottersen, O.P. (2009) New insights in cerebellar function. Introduction. Neuroscience 162: 545-548.
76. Tajti, J., Uddman, R., Moller, S., Sundler, F. and Edvinsson, L. ( 1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76: 176-183.
77. Thalakoti, S., Patil, V.V., Damodaram, S., Vause, C.V., Langford, L.E., Freeman, S.E. et al. (2007) Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology. Headache 47: 1008-1023; discussion 1024-1025.
78. Ueda, T., Ugawa, S., Saishin, Y. and Shimada, S. ( 2001) Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Brain Res Mol Brain Res 93: 36-45.
79. Unger, J.W. and Lange, W. ( 1991) Immunohistochemical mapping of neurophysins and calcitonin gene-related peptide in the human brainstem and cervical spinal cord. J Chem Neuroanat 4: 299-309.
80. Vause, C.V. and Durham, P.L. (2010) Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: Findings from array analysis. Neurosci Lett 473: 163-167.
81. Vincent, M. and Hadjikhani, N. ( 2007) The cerebellum and migraine. Headache 47: 820-833.
82. Weiller, C., May, A., Limmroth, V., Juptner, M., Kaube, H., Schayck, R.V. et al. (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1: 658-660.
83. Wolff, H.G. ( 1938) Headache and cranial arteries. Trans Assoc Am Physicians 53: 193-198.
84. Zhang, Z., Winborn, C.S., Marquez De Prado, B. and Russo, A.F. ( 2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27: 2693-2703.